"The new omicron variant could increase the likelihood that people will need a fourth coronavirus vaccine dose earlier than expected, executives at pharmaceutical giant Pfizer said Wednesday. Boosters are likely to help control the variant, according to the company, which said early lab experiments suggest the standard two-dose regimen still provides some protection against severe illness from the variant."